HOME >> BIOLOGY >> NEWS
Molecular motor implicated in tissue remodeling

St. Louis, Sept. 30, 2004--A well-known enzyme present in the skin and other tissues turns out to be a molecule-sized motor that extracts its fuel from the road it runs on, according to researchers at Washington University School of Medicine in St. Louis. Their discovery appears in the Oct. 1 issue of Science.

The enzyme, MMP-1, is a member of a group of enzymes that breaks down collagen, a fibrous substance that constitutes the foundation of the extracellular matrix that supports the cells in the body's tissues.

"By digesting collagen, enzymes such as MMP-1 initiate tissue remodeling, which can have a variety of purposes from organ development to tissue repair to metastatic invasion of tumors," says senior author Gregory Goldberg, Ph.D., professor of dermatology and of biochemistry and molecular biophysics. "Because they participate in all basic tissue metabolism, we want to understand how they function."

Goldberg and his colleagues Savees Saffarian, Ivan Collier, Barry Marmer and Elliot Elson found that MMP-1 operates as a molecular motor--a molecule that converts chemical energy into motion. "This is the only extracellular motor known," says Elson, Ph.D., coauthor and professor of biochemistry and molecular biophysics.

The research team discovered that MMP-1 moves along a collagen filament with a net unidirectional motion. One-way motion indicates that energy is being utilized, so the team looked for an energy source.

While most molecules that act as motors are inside cells and get their energy from a ubiquitous high-energy molecule called ATP, the team found that MMP-1 gets its energy by breaking the molecular bonds in the collagen filament it is attached to.

"In fact," Goldberg says, "with our model, a whole new principle emerges in which molecular motors in the extracellular matrix operate by extracting energy from the very track they move upon."

The researchers propose that the molecular motor contrib
'"/>

Contact: Gwen Ericson
ericsong@wustl.edu
314-286-0141
Washington University School of Medicine
30-Sep-2004


Page: 1 2

Related biology news :

1. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
2. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
3. Molecular staples shape a cancer killer
4. Molecular motor myosin VI moves hand over hand, researchers say
5. Molecular therapeutics advance fight against brain cancer
6. Molecular motor shuttles key protein in response to light
7. Molecular traffic cop directs cellular signals
8. Molecular marker predicts success of breast cancer treatment
9. Molecular image of genotoxin reveals how bacteria damage human DNA
10. Molecular mechanism found that may improve ability of stem cells to fight disease
11. Molecular midwives hold clues to the origin of life

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/9/2019)... ... March 09, 2019 , ... Hello ... ligands – exciting compounds for scientists studying GPCR and DREADD signalling. Hello Bio ... the National Institute of Neurological Disorders and Stroke, both institutes of the National ...
(Date:2/27/2019)... ... , ... Fluxion Biosciences, a leading developer of precision solutions for life science ... for further development of its ERASE-Seq liquid biopsy technology. The Phase I grant will ... Omar Mian at the Cleveland Clinic. , Liquid biopsies offer the potential to improve ...
(Date:2/22/2019)... ... 2019 , ... As technology continues to drive the pace ... and medical science grows ever thinner. As medical machines and the computers that ... medical practice easier for doctors, more effective for patients and more cost effective ...
Breaking Biology News(10 mins):
(Date:3/19/2019)... Calif. (PRWEB) , ... March 19, 2019 , ... ... Konica Minolta, Inc. (Konica Minolta) today announced the formation of their inaugural Scientific ... the advancement of precision medicine that takes into account individual variability in genes, ...
(Date:3/19/2019)... BASEL, Switzerland (PRWEB) , ... ... ... Center at Tel HaShomer, the largest hospital in Israel and the Middle ... cell-therapy manufacturing using the state-of-the-art Cocoon™ manufacturing platform. The partnership will enable ...
(Date:3/18/2019)... ... March 18, 2019 , ... For more than 15 years, ... that allow life science companies to easily comply with FDA 21 CFR Part 11 ... is a managed service delivering end-to-end GxP compliance from vendor audit through ongoing validation ...
(Date:3/14/2019)... ... March 14, 2019 , ... ... facility in Oklahoma City, OK. EyeCRO joins the Department of Veterans Affairs, the ... Sciences Center as the fifth institution in Oklahoma to receive this prestigious endorsement. ...
Breaking Biology Technology:
Cached News: